Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02645149
Title Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma (MatchMel)
Acronym MatchMel
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.